Hodgkin Lymphoma Clinical Trials in Minneapolis

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Donor Search Prognosis Score
  • Duarte, California
  • +51 more
2021-12-01
Dec 1, 2021
M
Recruiting
  • Hodgkin Lymphoma
  • pembrolizumab
  • +9 more
  • Birmingham, Alabama
  • +82 more
2021-11-18
Nov 18, 2021
M
Recruiting
  • Acute Leukemia
  • +24 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
2021-11-04
Nov 4, 2021
C
Recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Assessment of Therapy Complications
  • Questionnaire Administration
  • Birmingham, Alabama
  • +163 more
2021-09-03
Sep 3, 2021
C
Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
2021-09-02
Sep 2, 2021
V
Recruiting
  • Hodgkin Lymphoma
  • Chicago, Illinois
  • +3 more
2021-08-17
Aug 17, 2021
M
Active, not recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • Fludarabine (FLU)
  • +8 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
2021-08-13
Aug 13, 2021
M
Completed
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +36 more
2021-02-01
Feb 1, 2021
M
Active, not recruiting
  • Hodgkin Lymphoma
  • brentuximab vedotin
  • +4 more
  • Birmingham, Alabama
  • +215 more
2020-12-01
Dec 1, 2020
M
Recruiting
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
2020-09-29
Sep 29, 2020
M
Terminated
  • Acute Lymphoblastic Leukemia
  • +17 more
  • Infusion of Treg
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
2020-09-08
Sep 8, 2020
M
Completed
  • Acute Myelogenous Leukemia
  • +7 more
  • iTreg
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
2019-01-17
Jan 17, 2019